OBGYN PANEL TESTING
Here at Precision Labs, we are missioned with providing our clients with innovative, timely, and quality medical laboratory services. Our laboratory offers comprehensive OBGYN, Urology, and Podiatry testing. For partnerships and further testing information feel free to contact us (contact us should be underlined to link the email).
If you don’t see a pathogen that you regluarly test for please reach out to us and we can add it to your panel.
| Pathogens detected: | |||
|---|---|---|---|
| Candida albicans | Enterococcus faecalis | Providencia stuartii | Ureaplasma urealyticum |
| Candida tropicalis | Klebsiella oxytoca | Pseudomonas aeruginosa | Endogenous Control |
| Candida parapsilosis | Klebsiella pneumoniae | Serratia marcescens | |
| Candida glabrata | Mycoplasma hominis | Staphylococcus aureus | |
| E.Coli | Morganella morganii | Staphylococcus saprophyticus | |
| Enterobacter cloacae | Proteus mirabilis | Streptococcus agalactiae |
Pathogens detected:
- Candida albicans
- Candida tropicalis
- Candida parapsilosis
- Candida glabrata
- E.Coli
- Enterobacter cloacae
- Enterococcus faecalis
- Klebsiella oxytoca
- Klebsiella pneumoniae
- Mycoplasma hominis
- Morganella morganii
- Proteus mirabilis
- Providencia stuartii
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus aureus
- Staphylococcus saprophyticus
- Streptococcus agalactiae
- Ureaplasma urealyticum
- Endogenous Control
Symptoms to consider:
Those patients aff may experience some of the following symptoms:
A strong, persistent urge to urinate: a burning sensation when urinating: and passing frequent: small amounts of urine: urine that appears cloudy: urine that appears red: bright pink or cola-colored — a sign of blood in the urine and strong-smelling urine
Collection methods:
The UTI panel can use samples collected with the following in accordance with FDA standards:
Urine Collection
Compatible equipment:
KingFisher Flex, HT Centrifuge, Quant Studio 5
| Pathogens detected: | |||
|---|---|---|---|
| Chlamydia trachomatis | Mycoplasma genitalium | ||
| Gardnerella vaginalis | Mycoplasma hominis | ||
| Haemophilus ducreyi | Treponema pallidum | ||
| Herpes simplex 1 | Trichomonas vaginalis | ||
| Herpes simplex 2 | Ureaplasma urealyticum | ||
| Neisseria gonorrhoeae | Endogenous Control |
Pathogens detected:
- Chlamydia trachomatis
- Gardnerella vaginalis
- Haemophilus ducreyi
- Herpes simplex 1
- Herpes simplex 2
- Neisseria gonorrhoeae
- Mycoplasma genitalium
- Mycoplasma hominis
- Treponema pallidum
- Trichomonas vaginalis
- Ureaplasma urealyticum
- Endogenous Control
Symptoms to consider:
Those patients aff may experience some of the following symptoms:
Unusual discharge from the penis, vagina, or anus: pain during urination: sores, blisters, ulcers, warts or rashes in the genital area: pain in the scrotum or testicles: lumps and bumps on the genitals
Collection methods:
The STI panel can use samples collected with the following in accordance with FDA standards:
Urine C&S Tube
Endocervical Swab
Cervical Brush w/ Pap Smear media
Urethral Swab
Compatible equipment:
KingFisher Flex, HT Centrifuge, Quant Studio 5
Resistance markers detected:
| Assay | Resistance Markers | ||
|---|---|---|---|
| HPV-01 Strain 16 | Human papillomavirus (HPV) Strain 16 | ||
| HPV-02 Strain 18 | Human papillomavirus (HPV) Strain 18 | ||
| HPV-03 Strain 31 | Human papillomavirus (HPV) Strain 31 | ||
| HPV-04 Strain 33 | Human papillomavirus (HPV) Strain 33 | ||
| HPV-05 Strain 35 | Human papillomavirus (HPV) Strain 35 | ||
| HPV-06 Strain 39 | Human papillomavirus (HPV) Strain 39 | ||
| HPV-07 Strain 45 | Human papillomavirus (HPV) Strain 45 | ||
| HPV-08 Strain 51 | Human papillomavirus (HPV) Strain 51 | ||
| HPV-09 Strain 52 | Human papillomavirus (HPV) Strain 52 | ||
| HPV-10 Strain 56 | Human papillomavirus (HPV) Strain 56 | ||
| HPV-11 Strain 58 | Human papillomavirus (HPV) Strain 58 | ||
| HPV-12 Strain 59 | Human papillomavirus (HPV) Strain 59 | ||
| HPV-13 Strain 66 | Human papillomavirus (HPV) Strain 66 | ||
| HPV-14 Strain 67 | Human papillomavirus (HPV) Strain 67 | ||
| HPV-15 Strain 68 | Human papillomavirus (HPV) Strain 68 | ||
| HPV-Endogenous Control | *Endogenous Control |
Assay
- HPV-01 Strain 16
- HPV-02 Strain 18
- HPV-03 Strain 31
- HPV-04 Strain 33
- HPV-05 Strain 35
- HPV-06 Strain 39
- HPV-07 Strain 45
- HPV-08 Strain 51
- HPV-09 Strain 52
- HPV-10 Strain 56
- HPV-11 Strain 58
- HPV-12 Strain 59
- HPV-13 Strain 66
- HPV-14 Strain 67
- HPV-15 Strain 68
- HPV-Endogenous Control
Resistance Markers
- Human papillomavirus (HPV) Strain 16
- Human papillomavirus (HPV) Strain 18
- Human papillomavirus (HPV) Strain 31
- Human papillomavirus (HPV) Strain 33
- Human papillomavirus (HPV) Strain 35
- Human papillomavirus (HPV) Strain 39
- Human papillomavirus (HPV) Strain 45
- Human papillomavirus (HPV) Strain 51
- Human papillomavirus (HPV) Strain 52
- Human papillomavirus (HPV) Strain 56
- Human papillomavirus (HPV) Strain 58
- Human papillomavirus (HPV) Strain 59
- Human papillomavirus (HPV) Strain 66
- Human papillomavirus (HPV) Strain 67
- Human papillomavirus (HPV) Strain 68
- *Endogenous Control
Symptoms to consider:
Those patients aff may experience some of the following symptoms:
Cervical cancer, genital warts, common warts, plantar warts, and flat warts.
Collection methods:
The HPV panel can use samples collected with the following in accordance with FDA standards:
Vaginal or Cervical swab
Compatible equipment:
KingFisher Flex, HT Centrifuge, Quant Studio 5
Resistance markers detected:
| Assay | Resistance Markers | ||
|---|---|---|---|
| ABR-01 | Temoniera-β-lactamase (TEM) | ||
| ABR-02 | Sulfhydryl Variable-β-lactamase (SHV) | ||
| ABR-03 | Klebsiella pneumoniae carbapenemase (KPC) | ||
| ABR-04 | CefoTaXime-M-β-lactamase (CTXM 1) | ||
| ABR-05 | CefoTaXime-M-β-lactamase (CTXM 2) | ||
| ABR-06 | CefoTaXime-M-β-lactamase (CTXM 8) | ||
| ABR-07 | CefoTaXime-M-β-lactamase (CTXM 9) | ||
| ABR-08 | CefoTaXime-M-β-lactamase (CTXM 25) | ||
| ABR-09 | New Delhi metallo-β-lactamase (NDM) | ||
| ABR-10 | Verona integron-encoded metallo-β-lactamase (VIM) | ||
| ABR-11 | Verona integron-encoded metallo-β-lactamase (VIM 7) | ||
| ABR-12 | Verona integron-encoded metallo-β-lactamase (VIM 13) | ||
| ABR-13 | Cephamycinase (CMY 1) | ||
| ABR-14 | Cephamycinase (CMY 2) | ||
| ABR-15 | Cefoxitin-Hydrolyzing Class C-β-lactamase (FOX) | ||
| ABR-16 | Oxacillinase Group (OXA 1) | ||
| ABR-17 | Oxacillinase Group (OXA 2) | ||
| ABR-18 | Oxacillinase Group (OXA 48) | ||
| ABR-19 | Methicillin Resistence (mecA) | ||
| ABR-20 | Sulfonamide-Resistant isolate (Sul 1) | ||
| ABR-21 | Sulfonamide-Resistant isolate (Sul 2) | ||
| ABR-22 | Sulfonamide-Resistant isolate (Sul 3) | ||
| ABR-23 | Erythromycin Resistance Gene (ermB) | ||
| ABR-24 | Plasmid-Mediated Quinolone Resistance Determinant (qnrA 1) | ||
| ABR-25 | Plasmid-Mediated Quinolone Resistance Determinant (qnrB 1) | ||
| ABR-26 | Plasmid-Mediated Quinolone Resistance Determinant (qnrB 5) | ||
| ABR-27 | Plasmid-Mediated Quinolone Resistance Determinant (qnrS) | ||
| ABR-28 | Vancomycin Resistance (Van A) | ||
| ABR-29 | Vancomycin Resistance (Van B) | ||
| ABR-30 | Vancomycin Resistance (VanC 1) | ||
| ABR-31 | Vancomycin Resistance (VanC 2-4) | ||
| ABR-32 | Endogenous Control |
Assay
- ABR-01
- ABR-02
- ABR-03
- ABR-04
- ABR-05
- ABR-06
- ABR-07
- ABR-08
- ABR-09
- ABR-10
- ABR-11
- ABR-12
- ABR-13
- ABR-14
- ABR-15
- ABR-16
- ABR-17
- ABR-18
- ABR-19
- ABR-20
- ABR-21
- ABR-22
- ABR-23
- ABR-24
- ABR-25
- ABR-26
- ABR-27
- ABR-28
- ABR-29
- ABR-30
- ABR-31
- ABR-32
Resistance Markers
- Temoniera-β-lactamase (TEM)
- Sulfhydryl Variable-β-lactamase (SHV)
- Klebsiella pneumoniae carbapenemase (KPC)
- CefoTaXime-M-β-lactamase (CTXM 1)
- CefoTaXime-M-β-lactamase (CTXM 2)
- CefoTaXime-M-β-lactamase (CTXM 8)
- CefoTaXime-M-β-lactamase (CTXM 9)
- CefoTaXime-M-β-lactamase (CTXM 25)
- New Delhi metallo-β-lactamase (NDM)
- Verona integron-encoded metallo-β-lactamase (VIM)
- Verona integron-encoded metallo-β-lactamase (VIM 7)
- Verona integron-encoded metallo-β-lactamase (VIM 13)
- Cephamycinase (CMY 1)
- Cephamycinase (CMY 2)
- Cefoxitin-Hydrolyzing Class C-β-lactamase (FOX)
- Oxacillinase Group (OXA 1)
- Oxacillinase Group (OXA 2)
- Oxacillinase Group (OXA 48)
- Methicillin Resistence (mecA)
- Sulfonamide-Resistant isolate (Sul 1)
- Sulfonamide-Resistant isolate (Sul 2)
- Sulfonamide-Resistant isolate (Sul 3)
- Erythromycin Resistance Gene (ermB)
- Plasmid-Mediated Quinolone Resistance Determinant (qnrA 1)
- Plasmid-Mediated Quinolone Resistance Determinant (qnrB 1)
- Plasmid-Mediated Quinolone Resistance Determinant (qnrB 5)
- Plasmid-Mediated Quinolone Resistance Determinant (qnrS)
- Vancomycin Resistance (Van A)
- Vancomycin Resistance (Van B)
- Vancomycin Resistance (VanC 1)
- Vancomycin Resistance (VanC 2-4)
- Endogenous Control
| Pathogens detected: | |||
|---|---|---|---|
| Atopobium vaginae | Escherichia coli | Mycoplasma hominis | |
| BVAB2 | Enterococcus faecalis | Megasphaera 1 & 2 | |
| Candida albicans | Gardnerella vaginalis | Streptococcus agalactiae | |
| Candida glabrata | Lactobacillus crispatus | Staphylococcus aureus | |
| Candida parapsilosis | Lactobacillus iners | Ureaplasma urealyticum | |
| Candida tropicalis | Lactobacillus jensenii | Endogenous Control |
Pathogens detected:
- Atopobium vaginae
- BVAB2
- Candida albicans
- Candida glabrata
- Candida parapsilosis
- Candida tropicalis
- Escherichia coli
- Enterococcus faecalis
- Gardnerella vaginalis
- Lactobacillus crispatus
- Lactobacillus iners
- Lactobacillus jensenii
- Mycoplasma hominis
- Megasphaera 1 & 2
- Streptococcus agalactiae
- Staphylococcus aureus
- Ureaplasma urealyticum
- Endogenous Control
Symptoms to consider:
Those patients aff may experience some of the following symptoms:
UTI or STI symptoms: pain in the abdomen (stabbing or cramping): nausea, vomiting, or dizziness
Collection methods:
The women’s health panel can use samples collected with the following swab types:
Endocervical Swab
Compatible equipment:
KingFisher Flex, HT Centrifuge, Quant Studio 5
DOWNLOAD OUR COMPREHENSIVE OBGYN PANEL TEST
DO NOT SEE A PATHOGEN THAT YOU REGULARLY TEST FOR?
Let us know and we can add it to your panel
RESULTS DRIVEN, EVERYTIME
RAPID RESULTS
Unlike other testing facilities, we can guarantee results within 12-24 hours depending on the geographical location of your business and shipping schedules.
PROXIMITY
Our labs are strategically located nationwide, ensuring fast and reliable test results within 12-24 hours.
WE ARE PAPERLESS!
Our efficient and innovative LIS software system is extremely easy to use and we provide training to your staff in less than 30 minutes, optimizing the data entry process for you and your staff. We send you labels and a label printer at no additional charge.
ZERO COST TO YOU
We provide you With all needed supplies for specimen collection. In addition, we provide you With UPS critical care bags and labels from your office to our lab
PERSONALIZED CUSTOMER SERVICE
We pride ourselves on creating personal relationships With our clients, giving you quality service that larger laborites are not able to offer.
